首页 | 本学科首页   官方微博 | 高级检索  
     


Risk of Developing Fibroadenoma with the Use of Cyclosporine A in Renal Transplant Recipients
Authors:Figen Binokay  Mustafa Balal  Erkan Demir  Saime Paydas  Sureyya Soyupak  Yasar Sertdemir
Affiliation:1. Department of Radiology, Faculty of Medicine, Cukurova University, Balcali Adana, Turkeyfbinokay@cu.edu.tr;3. Department of Nephrology, Faculty of Medicine, Cukurova University, Balcali Adana, Turkey;4. Department of Urology, Faculty of Medicine, Cukurova University, Balcali Adana, Turkey;5. Department of Radiology, Faculty of Medicine, Cukurova University, Balcali Adana, Turkey;6. Department of Biostatistics, Faculty of Medicine, Cukurova University, Balcali Adana, Turkey
Abstract:To investigate the effect of cyclosporine A (Cyc A) on the development of fibroadenomas, 30 renal transplant patients and 20 chronic renal failure patients on dialysis were breast examined with ultrasonography and/or mammography. Of the renal transplant patients, 17 were receiving Cyc A-based combination therapy for immunosuppression. All patients were female with the age range of 29.7 ± 9.2 years in the transplant group and 33.95 ± 9.91 in the dialysis group. Eight of the 17 patients receiving Cyc A had fibroadenomas, 5 of them having bilateral lesions. None of the other patients, those on dialysis and on non-Cyc A combination therapy had fibroadenomas. A significant difference for fibroadenoma incidence in patients receiving Cyc A combination immunosuppression was found.
Keywords:cyclosporine A (Cyc A)  fibroadenoma  renal transplantation  chronic renal failure (CRF)  ultrasonography
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号